Schizophrenia Research

SJR Rank #3,489H-index: 211SJR: 1.230Best quartile: Q1APC: US$3,910
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Psychiatry and Mental HealthQ1
  • Biological PsychiatryQ2

Areas: Medicine · Neuroscience

Most published research topics

Schizophrenia research and treatmentMental Health and PsychiatryFunctional Brain Connectivity StudiesBipolar Disorder and TreatmentTryptophan and brain disordersMental Health Research TopicsAdvanced Neuroimaging Techniques and ApplicationsMental Health Treatment and AccessChild and Adolescent Psychosocial and Emotional DevelopmentPsychosomatic Disorders and Their Treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs035070010501400

Documents per Year

202220250150300450600

Detailed Information

ISSN

0920-9964, 1573-2509

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

2.92

References per Document

53.33

Coverage

1988-2026

Scope

As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership! Schizophrenia Research's time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue. The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.

Metrics from SCImago Journal Rank 2025. View on SCImago